Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Adi Sabag"'
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundCD72 is a highly required regulatory molecule in B cells. Its sufficient expression is crucial for maintaining self-tolerance. In contrast, soluble CD72 (sCD72) is reported to be increased in the serum of autoimmune diseases such as systemi
Externí odkaz:
https://doaj.org/article/5519b4f76404491ab4df9bbd7b7f7445
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Regulatory molecules have recently been recognized for their beneficial effects in the treatment of immune-mediated diseases, rather than using cytotoxic immune-suppressing drugs, which are associated with many unwanted side effects. Semaphorin3A (se
Externí odkaz:
https://doaj.org/article/79103c5b5f914554a115294df19d22e5
Autor:
Natalia Kreiniz, Nasreen Eiza, Tamar Tadmor, Adi Sabag, Sarah Matarasso Greenfeld, Ilana Levy, Celia Surio, Ekaterina Votinov, Raeda Mubariki, Aaron Polliack, Elias Toubi, Zahava Vadasz
Publikováno v:
Blood. 140:7112-7113
Autor:
Lobna, Matanis, Nasren, Eiza, Adi, Sabag, Jacob, Bejar, Giménez-Arnau, Ana M.., Marcus, Maurer, Zahava, Vadasz, Universitat Autònoma de Barcelona
Publikováno v:
Biomolecules, Vol 11, Iss 373, p 373 (2021)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biomolecules
Volume 11
Issue 3
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Biomolecules
Volume 11
Issue 3
Background: Patients with chronic spontaneous urticaria (CSU), an autoimmune disorder, show increased skin expression of IL-17A and can benefit from treatment with the anti-IL-17A biologic secukinumab. The mechanisms that drive IL-17A expression in C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5217561bf403abcabcbf0182a337a3
http://hdl.handle.net/10230/48357
http://hdl.handle.net/10230/48357
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tamar Tadmor, Lior Rokach, Gilad Itchaki, Pia Raanani, Adi Sabag, Shahar Rotem, Erez Bar-Haim, Ohad Benjamini, Helly Vernitsky, Hila Cohen, Osnat Bairey, Uri Elia
Publikováno v:
Blood
Background: Patients with chronic lymphocytic leukemia (CLL) are known to have a suboptimal immune response of both humoral and cellular arms. Recently, a BNT162b2 mRNA COVID-19 vaccine was introduced with a high efficacy of 95% in immunocompetent in
Autor:
Doron, Rimar, Merav, Lidar, Nasrin, Eiza, Adi, Sabag D, Elias, Toubi, Gleb, Slobodin, Itzhak, Rosner, Michael, Rozenbaum, Zahava, Vadasz
Publikováno v:
Inflammation; Apr2022, Vol. 45 Issue 2, p603-609, 7p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lobna M; The Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, The Rappaport Faculty of Medicine, Technion, Haifa 31048, Israel., Nasren E; The Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, The Rappaport Faculty of Medicine, Technion, Haifa 31048, Israel., Adi S; The Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, The Rappaport Faculty of Medicine, Technion, Haifa 31048, Israel., Jacob B; Bnai-Zion Medical Center, The Division of Pathology, Haifa 31048, Israel., Maria GA; Department of Dermatology, Hospital del Mar, IMIM, Universitat Autonoma, 08016 Barcelona, Spain., Marcus M; Dermatological Allergology, Allergie-Centrum-Charite, Department of Allergy and Dermatology, Charite-Universitätsmedizin, 12529 Berlin, Germany., Zahava V; The Proteomic and Clinical Flow Cytometry Unit, Bnai-Zion Medical Center, The Rappaport Faculty of Medicine, Technion, Haifa 31048, Israel.
Publikováno v:
Biomolecules [Biomolecules] 2021 Mar 02; Vol. 11 (3). Date of Electronic Publication: 2021 Mar 02.